Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 37469 | 57 | 41.3 | 94% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 405 | 3 | BACTERIORHODOPSIN//G PROTEIN COUPLED RECEPTOR//G PROTEIN | 29641 |
| 2998 | 2 | RGS PROTEINS//GIRDIN//RGS | 2563 |
| 37469 | 1 | AML CELL DEATH//ARSENIC TRIOXIDE 1//ATPASE BINDING CASSETTE ABC TRANSPORTERS | 57 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | AML CELL DEATH | authKW | 535714 | 2% | 100% | 1 |
| 2 | ARSENIC TRIOXIDE 1 | authKW | 535714 | 2% | 100% | 1 |
| 3 | ATPASE BINDING CASSETTE ABC TRANSPORTERS | authKW | 535714 | 2% | 100% | 1 |
| 4 | CARDIOPULM GENET PROGRAM | address | 535714 | 2% | 100% | 1 |
| 5 | DRUG SCREEN APPROACHES | authKW | 535714 | 2% | 100% | 1 |
| 6 | G0 G1 PHASE CELL CYCLE ARREST | authKW | 535714 | 2% | 100% | 1 |
| 7 | GAQ | authKW | 535714 | 2% | 100% | 1 |
| 8 | GASTROENTEROL HEPATOLGY | address | 535714 | 2% | 100% | 1 |
| 9 | HEMATOL ONCOLULSAN UNIV HOSP | address | 535714 | 2% | 100% | 1 |
| 10 | K562 CELLS GROWTH | authKW | 535714 | 2% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Hematology | 675 | 33% | 0% | 19 |
| 2 | Oncology | 201 | 32% | 0% | 18 |
| 3 | Immunology | 51 | 16% | 0% | 9 |
| 4 | Cell Biology | 44 | 16% | 0% | 9 |
| 5 | Pharmacology & Pharmacy | 31 | 16% | 0% | 9 |
| 6 | Biochemistry & Molecular Biology | 15 | 18% | 0% | 10 |
| 7 | Biochemical Research Methods | 10 | 5% | 0% | 3 |
| 8 | Biophysics | 8 | 5% | 0% | 3 |
| 9 | Medicine, Research & Experimental | 7 | 5% | 0% | 3 |
| 10 | Chemistry, Medicinal | 5 | 4% | 0% | 2 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CARDIOPULM GENET PROGRAM | 535714 | 2% | 100% | 1 |
| 2 | GASTROENTEROL HEPATOLGY | 535714 | 2% | 100% | 1 |
| 3 | HEMATOL ONCOLULSAN UNIV HOSP | 535714 | 2% | 100% | 1 |
| 4 | METABOL CELL BIOL PLATFORM | 535714 | 2% | 100% | 1 |
| 5 | OPTOSE CANCET IMMUN | 535714 | 2% | 100% | 1 |
| 6 | PHYSIOPATHOL TOULOUSE PURPANINSERM U563 | 535714 | 2% | 100% | 1 |
| 7 | SERV HEMATOL BIOL COCHINCNRSINSERM U567 | 535714 | 2% | 100% | 1 |
| 8 | SERV PHARMACIE | 535714 | 2% | 100% | 1 |
| 9 | SOPHISTICATED | 535714 | 2% | 100% | 1 |
| 10 | AFFILIATED CLIN CHENGDU 2 | 267856 | 2% | 50% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | LEUKEMIA RESEARCH | 1417 | 7% | 0% | 4 |
| 2 | IMMUNOLOGY AND CELL BIOLOGY | 933 | 4% | 0% | 2 |
| 3 | BMC IMMUNOLOGY | 795 | 2% | 0% | 1 |
| 4 | JOURNAL OF HEMATOLOGY & ONCOLOGY | 793 | 2% | 0% | 1 |
| 5 | JOURNAL OF IMMUNOLOGY RESEARCH | 658 | 2% | 0% | 1 |
| 6 | HEMATOLOGICAL ONCOLOGY | 625 | 2% | 0% | 1 |
| 7 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 607 | 4% | 0% | 2 |
| 8 | ACS CHEMICAL NEUROSCIENCE | 587 | 2% | 0% | 1 |
| 9 | COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY SERIES | 432 | 4% | 0% | 2 |
| 10 | CELL RESEARCH | 384 | 2% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | MAHMUD, H , KORNBLAU, SM , TER ELST, A , SCHERPEN, FJG , QIU, YH , COOMBES, KR , DE BONT, ESJM , (2016) EPIDERMAL GROWTH FACTOR RECEPTOR IS EXPRESSED AND ACTIVE IN A SUBSET OF ACUTE MYELOID LEUKEMIA.JOURNAL OF HEMATOLOGY & ONCOLOGY. VOL. 9. ISSUE . P. - | 8 | 62% | 1 |
| 2 | THEPOT, S , BOEHRER, S , SEEGERS, V , PREBET, T , BEYNE-RAUZY, O , WATTEL, E , DELAUNAY, J , RAFFOUX, E , HUNAULT, M , JOURDAN, E , ET AL (2014) A PHASE I/II TRIAL OF ERLOTINIB IN HIGHER RISK MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA AFTER AZACITIDINE FAILURE.LEUKEMIA RESEARCH. VOL. 38. ISSUE 12. P. 1430 -1434 | 8 | 47% | 4 |
| 3 | SAYAR, H , CZADER, M , AMIN, C , CANGANY, M , KONIG, H , CRIPE, LD , (2015) PILOT STUDY OF ERLOTINIB IN PATIENTS WITH ACUTE MYELOID LEUKEMIA.LEUKEMIA RESEARCH. VOL. 39. ISSUE 2. P. 170 -172 | 5 | 56% | 1 |
| 4 | DEANGELO, DJ , NEUBERG, D , AMREIN, PC , BERCHUCK, J , WADLEIGH, M , SIRULNIK, LA , GALINSKY, I , GOLUB, T , STEGMAIER, K , STONE, RM , (2014) A PHASE II STUDY OF THE EGFR INHIBITOR GEFITINIB IN PATIENTS WITH ACUTE MYELOID LEUKEMIA.LEUKEMIA RESEARCH. VOL. 38. ISSUE 4. P. 430-434 | 10 | 27% | 6 |
| 5 | HE, Y , HUANG, Y , TU, L , LUO, J , YU, B , QIAN, HY , DUAN, LH , SHI, GX , (2016) DECREASED GAQ EXPRESSION IN T CELLS CORRELATES WITH ENHANCED CYTOKINE PRODUCTION AND DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS.ONCOTARGET. VOL. 7. ISSUE 52. P. 85741 -85749 | 8 | 31% | 0 |
| 6 | HEO, SK , NOH, EK , YOON, DJ , JO, JC , CHOI, Y , KOH, S , BAEK, JH , PARK, JH , MIN, YJ , KIM, H , (2015) RADOTINIB INDUCES APOPTOSIS OF CD11B(+) CELLS DIFFERENTIATED FROM ACUTE MYELOID LEUKEMIA CELLS.PLOS ONE. VOL. 10. ISSUE 6. P. - | 7 | 26% | 3 |
| 7 | CHEN, YJ , FANG, LW , SU, WC , HSU, WY , YANG, KC , HUANG, HL , (2016) LAPATINIB INDUCES AUTOPHAGIC CELL DEATH AND DIFFERENTIATION IN ACUTE MYELOBLASTIC LEUKEMIA.ONCOTARGETS AND THERAPY. VOL. 9. ISSUE . P. 4453 -4464 | 8 | 20% | 0 |
| 8 | ZHANG, L , SHI, GX , (2016) GQ-COUPLED RECEPTORS IN AUTOIMMUNITY.JOURNAL OF IMMUNOLOGY RESEARCH. VOL. . ISSUE . P. - | 9 | 14% | 0 |
| 9 | LAINEY, E , WOLFROMM, A , MARIE, N , ENOT, D , SCOAZEC, M , BOUTELOUP, C , LEROY, C , MICOL, JB , DE BOTTON, S , GALLUZZI, L , ET AL (2013) AZACYTIDINE AND ERLOTINIB EXERT SYNERGISTIC EFFECTS AGAINST ACUTE MYELOID LEUKEMIA.ONCOGENE. VOL. 32. ISSUE 37. P. 4331-4342 | 6 | 13% | 17 |
| 10 | NOH, EK , KIM, H , PARK, MJ , BAEK, JH , PARK, JH , CHA, SJ , WON, JH , MIN, YJ , (2010) GEFITINIB ENHANCES ARSENIC TRIOXIDE (AS(2)O(3))-INDUCED DIFFERENTIATION OF ACUTE PROMYELOCYTIC LEUKEMIA CELL LINE.LEUKEMIA RESEARCH. VOL. 34. ISSUE 11. P. 1501 -1505 | 4 | 22% | 10 |
Classes with closest relation at Level 1 |